The effects of hypoinsulinemic nonketotic streptozotocin diabetes on hepatic apo B synthesis and secretion was studied in primary cultures of rat hepatocytes. Diabetic rats were characterized by their significantly elevated serum glucose, apo B, and triglyceride levels, while serum insulin levels were less than a third of normal. Serum transaminase activities of diabetic rats were significantly elevated when compared with control rats, which was attributed to an increase in liver transaminase activity in diabetic rats. The pattern of enzyme activities of hepatocytes reflected that observed in livers of donor rats and the pattern was retained by primary cultures of hepatocytes over the culture period. Hepatocytes from diabetic rats secreted only one third of the apo B secreted by hepatocytes from control rats, which was determined by monoclonal immunoassay of rat total apo B. Decreases in secretion were confirmed by measurement of secretory [35S~methionine-labeled lipoprotein apo B radioactivity. The decreased apo B content of media of hepatocytes from diabetic rats was not due to increased apo B catabolism since hepatocytes from diabetic rats were shown to degrade less lipoprotein-apo B than hepatocytes from normal rats in control experiments. In addition, the apo B content of detergent-solubilized hepatocytes from diabetic rats was significantly less than that of hepatocytes from control rats. These results suggest that insulin is necessary for normal hepatic apo B synthesis and secretion and that the hyperlipidemia associated with hypoinsulinemia in vivo is primarily of intestinal origin.
Introduction
Hyperlipidemia has been associated with human diabetes mellitus (1, 2) and with animal models of experimental diabetes (3-5), and is characterized by elevations of plasma apo B-containing lipoproteins. The atherogenic potential of such proteins (6) is consistent with the fact that diabetes is considered a significant risk factor for complications arising from premature atherosclerosis (7) . The primary mechanism responsible for the hyperlipidemia has been the subject of recent reports that indicate the importance of intestinal lipoproteins (4, 5) and of defects in peripheral and hepatic catabolism of triglyceride-rich lipoproteins (TRL)' and LDL through insulin-dependent processes (8) (9) (10) (11) . Several studies suggest that hepatically synthesized VLDL may contribute to the hyperlipoproteinemia associated with diabetes (12, 13). Other studies suggest that alterations in lipoprotein lipid content (14) and/or apolipoprotein composition (3-5) may be due to abnormal lipoprotein metabolism in diabetes and that these changes in composition may, in turn, influence subsequent catabolic events. To evaluate how hepatic apo B metabolism is affected by chronic hypoinsulinemia in vivo we undertook studies using primary cultures of hepatocytes from rats with nonketotic streptozotocin-induced diabetes. Primary cultures of hepatocytes are well suited for these studies since apo B secretory pathways can be evaluated without the complicating hormonal and substrate changes which are present in vivo. Our studies demonstrate that chronic hypoinsulinemia in vivo severely limits apo B synthesis and secretion by corresponding cultures of rat hepatocytes and suggest that normal lipoprotein B synthesis and secretion is dependent upon basal levels of endogenous insulin. These results support the concept that the hyperlipidemia and increased plasma apo B observed in streptozotocin diabetic rats is primarily of intestinal origin and is a result of a catabolic defect.
Methods
Animals. Male Sprague-Dawley rats fed ad lib. and weighing 200-280 g were used in all studies. Diabetes was induced by the injection of streptozotocin (85 mg/kg) (15) . Rats were bled by tail vein 6-20 d after streptozotocin injection and serum was prepared. Serum glucose was estimated by a glucose oxidase method (16); serum insulin (17) and apo B (18) were measured by RIA; cholesterol was estimated by a cholesterol oxidase method ( 19) and triglyceride by glycerol assay after enzymatic hydrolysis (20) . Serum alanine aminotransferase (ALT) (21) , aspartate aminotransferase (AST) (21) , and lactate dehydrogenase (LD) were also determined (22). Rats were used for hepatocyte preparation 6-20 d after streptozotocin injection and none of the rats used had positive urine ketones using Ames Keto-Diastix.
Preparation ofhepatocytes for primary culture. Hepatocytes were prepared for primary culture in serum-free media (23) and placed onto 60-or 100-mm sterile petri dishes coated with rat tail collagen (100 gg/ml). The dishes were incubated for 4 h at 37°C in an atmosphere of 95% air/5% CO2, after which the medium and nonadherent cells were discarded and adherent cells were washed three times with 2.0 ml of 10 mM sodium phosphate, pH 7.4, 139 mM sodium chloride, and 0.1%, wt/vol, BSA. Fresh media (2 ml/60-mm dish and 3 ml/100-mm dish) containing 0.2%, wt/vol, BSA was then added and cells were incubated overnight. At the conclusion of experiments and after the removal of media, cellular protein was determined (15, 23 (25) . Media lipoproteins were isolated by ultracentrifugation at salt densities of 1.063 g/ml and between 1.063 and 1.21 g/ml by the addition of solid sodium bromide as previously described (28). For control catabolic studies, lipoproteins were isolated at d < 1.006 g/ml for TRL and at 1.019 < d < 1.063 g/ml for LDL from sera ofnonfasted control rats by ultracentrifugation, and the lipoproteins were radioiodinated using a modified iodine monochloride procedure (29) . The apo B specific activities ofTRL and LDL that were used for the control studies were 22 and 54 dpm/ng, respectively. TCA precipitation was carried out as described previously (30). Alcohol 
Results
Characterization of the nonketotic streptozotocin diabetic rat.
The effect of streptozotocin diabetes on rat serum parameters are presented in Table I . Diabetic rats were characterized by their significant hypoinsulinemia and associated hyperglycemia. Serum triglycerides were significantly elevated in diabetic rats which was consistent with elevations of serum apo B. Compared with control rats, serum AST and ALT were significantly elevated by diabetes whereas LD was within normal limits. To distinguish whether elevated serum transaminases were due to liver damage or if they reflected increased intracellular enzyme activity, we determined the enzyme activity of whole livers from control and diabetic rats. Whole livers were preperfused for 10 min to remove blood before homogenization and analysis. As seen in Table II , the content of ALT and AST (shown in international units per liter per milligram of cell protein) in livers of diabetic rats was significantly greater than that of controls whereas the content of LD (in international units per liter per milligram of cell protein) in livers from diabetic rats was similar to controls. The ratios of serum enzyme activity (in international units per liter) to corresponding liver enzyme activity (in international units per liter per milligram of cell protein) were relatively constant for control and diabetic rats, [ALT, 0.50 and 0.52; AST, 0.11 and 0.14; and LD, 0.46 and 0.44, respectively]. These results suggest that the elevation of serum transaminase activities of diabetic rats was reflective of an increase in liver enzyme activity rather than due to liver damage.
To determine whether hepatocytes retained the characteristics ofthe liver in vivo, we compared liver enzyme patterns of control and diabetic rats with those from corresponding hepatocytes in primary culture (Table II) . Enzyme activities of hepatocytes per milligram of cell protein were greater than those of whole liver. This may be reflective of the nonparenchymal cells contained in whole liver preparations. As seen in Table II , the enzyme activity pattern of hepatocytes from diabetic and control rats corresponded to that obtained from perfused livers. Nonfasted rats were tail bled 6-20 d after injection of (85 mg/kg) buffered streptozotocin (diabetic rats) or buffer alone (control rats). Serum was prepared and analyzed as described in Methods. Results are from nine control and nine diabetic rats and are expressed as the mean±SD. * Significantly different from the control value at a probability level of at least P < 0.05 (unpaired t test). Primary cultures of hepatocytes from control and diabetic rats were cultured for 16 h, detergent solubilized using 0.5% Triton X-l00 containing buffer, and were assayed for enzyme content as described in Methods. Whole livers were preperfused for 10 min with PBS to remove residual plasma and I g was homogenized in 0.5% Triton X-100 containing buffer using a Polytron. Nonsoluble material was removed by centrifugation at 100,000 g and enzyme activity was determined on dilutions of the supernatants as described in Methods.
Results are expressed as the mean activity (in international units per liter) per milligram of solubilized protein±SD. * Significantly different from control value at a probability level of at least P < 0.05 (unpaired t test).
Viability ofhepatocytes ofcontrol and nonketotic diabetic rats. Because differences in hepatic lipoprotein secretion could relate to inherent differences in collagenase dispersion of livers from control and diabetic rats and in their subsequent viability, it was important to determine if hepatocytes isolated from control and diabetic rats were equally viable in primary culture. Collagenase-dispersed hepatocytes from control and diabetic rats were plated onto 60-mm dishes and hepatocellular enzyme activities were measured after cells adhered to culture dishes (initial) and after 21 h of incubation. We reasoned that the ability of cells to maintain cellular enzymes in culture was consistent with cell viability. As seen in Table III Effect ofdiabetes on apo B secretion and cellular apo B. To evaluate apo B secretion, hepatocytes from control and diabetic rats were cultured for 16 h after which the media was changed and the cells were incubated for an additional 5 h. Media apo B concentration was determined by monoclonal immunoassay ofthe 5-h media. Because we used both 60-and 100-mm dishes, we measured apo B secretion into the media under both culture conditions (Table IV) . Hepatocytes from detergent-solubilized cell extracts by monoclonal immunoassay, was similarly (37.5%) reduced in hepatocytes of diabetic rats compared with that of control rats in 60-mm culture dishes (Table IV) . The apo B content of sequential density fractions (d < 1.063 g/ml and 1.063 < d < 1.021 g/ml) isolated by ultracentrifugation was also measured (Table V) Control studies. Control studies were performed to determine whether the observed decrease in apo B secreted by hepatocytes from diabetic rats could be due to increased apo B degradation in the media. A concentration of apo B approximately equivalent to that secreted into the culture media in 5 h was used to reflect experimental conditions as described in Table IV . Plasma '251-TRL-apo B (190 ng apo B/ml media) and '25I-LDL-apo B (140 ng/ml media) isolated from control rats were added to triplicate plates ofhepatocytes from diabetic and control rats and were incubated for 16 h. Separate triplicate plates from each condition were incubated for 15 min to Hepatocytes from control and diabetic rats were cultured for 15 min and 16 h in the presence of added 251I-TRL (190 ng apo B/ml) and '251-LDL (140 ng apo B/ml) prepared from sera of nonfasted control rats. Three plates of hepatocytes were prepared and analyzed for each condition. The protein content of each plate was assayed and was 1.6±0.19 and 1.6±0.21 mg for hepatocytes of control and diabetic rats, respectively. * Apo B degradation was calculated from the loss of 2-propanol precipitable radioactivity of the 15-min and 16-h media and results are presented as the mean percent degraded±SD for triplicate plates. t Apo B degradation was calculated from the loss of radioactivity of SDS-PAGE gel slices containing apo BH and apo BL bands of the 15-min and 16-h media and results are expressed as the mean percent degraded±SD for triplicate plates. I Significantly different from the control value at a probability level of at least P < 0.05 (unpaired t test).
9.2±3.3% of added total '25I-LDL label (P < 0.06), respectively. Apo B degradation was quantitated by 2-propanol precipitation, by SDS-PAGE and gel slicing, and the results are summarized in Table VI . Using the alcohol precipitation method, hepatocytes ofdiabetic rats degraded significantly less apo B of TRL and LDL than controls. Autoradiographs of SDS gels ofthe media are seen in Fig. 2 and were used to locate apo B bands that were cut out in their entirety for radioassay. The difference in apo B radioactivity of the 1 5-min and 16-h samples was used to calculate the percent of degraded apo B (Table VI) . Using the SDS-PAGE and gel slicing method, results were more variable but consistent with the alcohol precipitation results. These control experiments demonstrate that the observed decrease in media apo B secreted by hepatocytes of diabetic rats was not due to increases in apo B degradation.
Discussion
The model of nonketotic diabetes in rats, which is induced by injection of streptozotocin, is characterized by hypoinsulinemia and hyperglycemia with associated hypertriglyceridemia and elevations of apo B-containing lipoproteins consistent with previous reports (3-5, 13). In diabetic rats, serum and liver transaminases are elevated, which possibly indicates an adaptive increase in diabetes that is consistent with enhancement of gluconeogenic pathways. The enzyme pattern of hepatocytes in primary culture parallels patterns of corresponding intact livers, which supports the idea that primary cultures of hepatocytes mirror the in vivo characteristics of the animal from which they were derived. Because differences in hepatic metabolism observed in primary cultures of hepatocytes may relate to differences in longevity of the cultured cells in vitro, we evaluated the viability of hepatocytes from normal and diabetic rats in control cultures. Five lines of evidence support the idea that hepatocytes from diabetic rats were as viable as those from control rats in primary cultures. First, hepatocytes from diabetic rats had sig- ng apo B/ml 125I-TRL (A) and 140 ng apo B/ml '23I-LDL (B) were added to culture media and incubated with hepatocytes from control (C) and diabetic (D) rats. After 15 min (a) and 16 h (b) the media was removed, 1.0 ml was delipidated, and apolipoproteins were separated by SDS-PAGE gels. After electrophoresis the gels were heat fixed and then autoradiographed as described in Methods.
nificantly higher ALT and AST enzyme activities than hepatocytes from control rats. Second, hepatocytes from control and diabetic rats had a distribution of hepatic enzyme activity (ALT, AST, LD) similar to corresponding intact livers, which indicates that they retained the adaptive changes that occurred in vivo. Third, cellular enzyme activity was maintained in hepatocytes over 21 h of culture. Fourth, there was minimal cell leakage during incubation since culture media contained < 2% of the cellular enzyme activity. Fifth, > 95% of hepatocytes from control and diabetic rats that adhere to the collagen-coated dishes are capable of excluding Trypan blue.
In the current studies, hepatocytes of nonketotic streptozotocin diabetic rats secreted only one-third of the apo B secreted by hepatocytes from control rats with concomitant decreases in the apo B content of d < 1.063 g/ml and 1.063 < d < 1.21 g/ml lipoprotein fractions. This finding was supported by stained gels (data not shown) and by results demonstrating that diabetic rats secreted less newly synthesized ([35S]-methionine labeled) apo BH, apo BL, and apo E compared with that secreted by the hepatocytes of control rats. In addition to impaired lipoprotein-apo B secretion by hepatocytes from diabetic rats, the cellular apo B concentration of these cells was significantly reduced when compared with that of control cells. The apo B content of hepatocytes from control rats by monoclonal immunoassay (18, 26) was similar to that reported by Patsch et al. (24) who used polyclonal RIA. These data support the concept that in hypoinsulinemic diabetes there is an alteration of net apo B synthesis rather than an imbalance of synthesis, assembly, and secretion. The decrease in intracellular apo B in diabetics may result in a decrease in available apo B for lipoprotein assembly and may be the result of decreased synthesis or, alternatively, of increased intracellular apo B turnover.
In control experiments 251I-TRL and '251I-LDL from normal rats were added to hepatocytes from control and diabetic rats to test the hypothesis that increased apo B degradation in the media might have contributed to the apparently decreased apo B concentration in media of hepatocytes from diabetic rats. Using 2-propanol precipitation, SDS-PAGE and gel slicing to assess apo B degradation, hepatocytes from diabetic rats degraded significantly less lipoprotein-apo B than hepatocytes from control rats over 16 h. This finding was confirmed by results obtained using TCA precipitation. Our studies demonstrated that 27% of TRL-apo B was degraded over 16 h by hepatocytes from control rats, which is in contrast to the results of Patsch et al. (24) who reported that < 15% of VLDL was degraded under similar culture conditions. Different results may be due to differences in the plating density, in the lipoprotein fractions used (TRL vs. VLDL), in apo BH and apo BL variant composition of the lipoprotein preparations (32) Studies of plasma lipoproteins of streptozotocin diabetic rats have shown that plasma apo B and triglyceride levels are significantly increased, while plasma apo E levels are decreased (3, 4). The current studies show hepatic lipoprotein secretion is severely impaired by hypoinsulinemia (approximately onethird normal) and secretory apo E as well as apo B are reduced. Our results, therefore, strongly support the idea that the observed increase in plasma apo B of streptozotocin diabetic rats in vivo is primarily of intestinal origin and is a result of a catabolic defect involving these lipoproteins. A defect in catabolic pathways that is shared by hepatic and intestinal apo B-containing lipoproteins would result in a combined form of hyperlipoproteinemia. Our studies further demonstrate that the catabolism of normal TRL and LDL is defective in the hepatocytes of diabetic rats which indicates that changes in lipoprotein apo E content alone could not account for the observed differences. These results suggest that there is an alteration of receptor-mediated apo B degradation in diabetes. Particularly interesting is the decreased degradation of apo BH (Fig. 2) , which suggests an alteration of LDL receptor-mediated processes in diabetics.
We (26) and others (24, 37, 38) have recently reported that high concentrations of insulin inhibit lipoprotein-apo B secretion by primary cultures of rat hepatocytes. Decreased hepatic triglyceride output in response to high portal insulin levels has been shown in human studies ( 12) to be consistent with the rat in vitro results. In light ofthe current findings it is necessary to postulate a dual role for insulin in hepatic apo B metabolism. The first is to maintain normal levels of cellular apo B synthesis, lipoprotein secretion, and catabolism on a chronic basis. The second is to acutely inhibit hepatic apo B synthesis and secretion at postprandial portal-vein insulin concentrations during chylomicron synthetic and lipolytic phases where rapid uptake of intestinal remnants by the liver occurs. As insulin levels fall during the interprandial period, hepatic VLDL secretion resumes, thereby balancing lipid delivery to peripheral tissues during the postprandial period.
